Advertisement

Topics

Entasis Publishes Data Highlighting the Potent and Differentiated Activity of ETX2514 Combinations against Drug Resistant Gram-negative Bacteria Including Acinetobacter and Pseudomonas

11:13 EDT 30 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Report in Nature Microbiology Describes Entasis’ Rational Design of a Next-generation Beta-Lactamase Inhibitor with an Expanded Spectrum of Beta-Lactamase Activity Entasis Therapeutics, a leader in the discovery and...

Other Sources for this Article

Company Contact
Entasis Therapeutics
Kyle Dow, 781-810-0114
kyle.dow@entasistx.com
or
Media Contact
MacDougall Biomedical Communications
Kari Watson or Stefanie Tuck, 781-235-3060
kwatson@macbiocom.com or stuck@macbiocom.com

NEXT ARTICLE

More From BioPortfolio on "Entasis Publishes Data Highlighting the Potent and Differentiated Activity of ETX2514 Combinations against Drug Resistant Gram-negative Bacteria Including Acinetobacter and Pseudomonas"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...